These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32144089)

  • 1. Safety of ceftriaxone in paediatrics: a systematic review.
    Zeng L; Wang C; Jiang M; Chen K; Zhong H; Chen Z; Huang L; Li H; Zhang L; Choonara I
    Arch Dis Child; 2020 Oct; 105(10):981-985. PubMed ID: 32144089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of ceftriaxone in paediatrics: a systematic review protocol.
    Zeng L; Choonara I; Zhang L; Xue S; Chen Z; He M
    BMJ Open; 2017 Aug; 7(8):e016273. PubMed ID: 28827252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].
    Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ
    Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of azithromycin in pediatrics: a systematic review and meta-analysis.
    Zeng L; Xu P; Choonara I; Bo Z; Pan X; Li W; Ni X; Xiong T; Chen C; Huang L; Qazi SA; Mu D; Zhang L
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1709-1721. PubMed ID: 32681202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
    Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
    J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric ceftriaxone nephrolithiasis.
    Gargollo PC; Barnewolt CE; Diamond DA
    J Urol; 2005 Feb; 173(2):577-8. PubMed ID: 15643261
    [No Abstract]   [Full Text] [Related]  

  • 18. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.